Engineers Gate Manager’s Pyxis Oncology PYXS Stock Holding History

Engineers Gate Manager’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,816	Closed	-$26.2K	–	2495
2025 Q4	$26.2K	Buy	+22,816	New	+$80.5K	﹤0.01%	2018

Other funds holding PYXS

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

GGI

GordonMD Global Investments Beverely Hills, California $144M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Engineers Gate Manager's PYXS Position: Q1 2026 in Review

Engineers Gate Manager sold out of Pyxis Oncology (PYXS) in Q1 2026, closing a stake of 22,816 shares — an estimated $26.2K sold.

Engineers Gate Manager first reported a position in PYXS in Q4 2025 and held it in 1 quarter. The position peaked at $26.2K in Q4 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

Engineers Gate Manager reported no remaining Pyxis Oncology position as of Q1 2026 after selling out during the quarter.
Engineers Gate Manager sold 22,816 Pyxis Oncology shares in Q1 2026, an estimated $26.2K.
Engineers Gate Manager first reported a position in Pyxis Oncology in Q4 2025 and held it in 1 quarter.
Engineers Gate Manager's Pyxis Oncology position peaked at $26.2K in Q4 2025.
78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.